VEINOPLUS®Rx Only

For licensed healthcare providers

Patients lose calf muscle while immobilized. Prescribe VEINOPLUS® in two minutes.

FDA-cleared NMES for disuse muscle atrophy (E0745). Most practices use drop-ship: you sign the Rx, DynaPulse delivers to the patient and handles billing.

Download the Rx Form Request a Demo Unit

Product questions? Call our 24/7 AI product assistant: (689) 263-7980

VEINOPLUS® device with electrode pads and lead Talk to our AI

Who it's for

Built for the practices that see disuse first

When a limb is casted, booted, or kept off weight, the muscle pays for it. These teams document that loss every week.

Podiatry / Foot & Ankle

Casting, boots, and non-weight-bearing after surgery or fracture. You already run DME workflows for bone stimulators.

Orthopedics / Sports Medicine

Atrophy builds during immobilization, before PT starts. NMES is an adjunct to rehabilitation, not a substitute.

PM&R

Deconditioning and disuse after injury or hospitalization, with an intact motor nerve.

Pain Management

Muscle rehabilitation only: patients with documented disuse atrophy and an intact motor nerve.

Wound Care / Primary Care

Offloading and inactivity can lead to disuse atrophy. Sensory neuropathy with preserved motor function does not disqualify a patient.

How it works for your practice

Two ways to get VEINOPLUS® to your patient

Pick the path that fits your practice. Either way, the prescribing decision and the documentation stay with you.

Path A · Most practices

Drop-Ship

No DME license, no inventory, no billing.

  1. Document the four pillars in the chart.
  2. Sign the Rx.
  3. Fax the Rx, demographics, insurance card, and chart note to (321) 641-4230 (HIPAA-secure).
  4. DynaPulse ships to the patient and bills.
Get the Rx Form
Path B · Existing suppliers

In-Office DME

For practices with a Medicare DMEPOS supplier number (PTAN).

  • Physicians furnishing DMEPOS only to their own patients are exempt from accreditation and the surety bond. A PTAN is still required.
  • Florida: MD, DO, and DC are exempt from AHCA HME licensure for e-stim (Fla. Stat. § 400.93(5)(l)).
  • DPMs are not on that exemption list. Confirm with your compliance advisor or use drop-ship.
Talk through Path B

What the chart needs

Four pillars of NCD 160.12

Medicare may cover VEINOPLUS® (E0745) for disuse muscle atrophy when NCD 160.12 criteria are met and documented. Coverage is determined by each payer.

Pillar 1

Objective atrophy

Record a measured girth or strength deficit.

Pillar 2

Intact motor nerve supply

Document that the motor nerve can fire.

Pillar 3

Non-neurological cause of disuse

State the cause, with dates.

Pillar 4

Reasonable & necessary

Explain why NMES is reasonable and necessary, and include a reassessment plan.

"Ordering muscle stimulator (VEINOPLUS®) for disuse muscular atrophy M62.562 and/or M62.561."

Coding: E0745 (capped rental, 13 months) · A4595 supply allowance · ICD-10 M62.561 / M62.562 · Modifiers RR + KH (mo 1) / KI (mo 2–3) / KJ (mo 4–13) + KX

Sales and education aid. Not billing or legal advice.

Office manager kit

Everything your staff needs to process an order

No sign-up to download. Items not yet posted are sent on request.

Rx Form

The VEINOPLUS® prescription, ready to complete and sign.

Download PDF

.veinoplus Dot Phrase

A typed shortcut that drops the documentation language into the chart.

Request via form

"Who to Flag" Screening Sheet

Help staff identify charts to bring to the prescriber.

Request via form

Billing Quick Reference

Codes and modifiers on one page for your billing team.

Request via form

VA Ordering Sheet

Prosthetics consult wording, FSS details, and the Community Care request process.

Download PDF

Clinical evidence

Disuse atrophy and NMES

General NMES evidence. These studies did not use VEINOPLUS® and mostly assessed the quadriceps, not the calf.

Casted tibial fracture

Seven men in a long-leg cast for 6 weeks used electrical stimulation; 14 similar patients did not. Quadriceps cross-sectional area fell a mean 17% without stimulation and was similar between legs with it.

Gibson JN, Smith K, Rennie MJ. Lancet. 1988;2(8614):767–770. doi:10.1016/s0140-6736(88)92417-8

Short-term knee immobilization

Twenty-four healthy young men, 5 days of one-leg immobilization. Twice-daily NMES prevented measurable quadriceps loss. It did not preserve strength.

Dirks ML, et al. Acta Physiol (Oxf). 2014;210(3):628–641. doi:10.1111/apha.12200

Narrative review of disuse

NMES can augment muscle protein synthesis and prevent or attenuate muscle loss during short-term disuse in various clinical populations.

Dirks ML, Wall BT, van Loon LJC. J Appl Physiol. 2018;125(3):850–861. doi:10.1152/japplphysiol.00985.2016

After total knee arthroplasty

Systematic review and meta-analysis, 9 RCTs, 691 patients. NMES improved quadriceps strength; the authors note many outcomes did not reach minimal clinically important difference.

Peng L, et al. Front Med (Lausanne). 2021;8:779019. doi:10.3389/fmed.2021.779019

Clinical Science

FDA-cleared indications and circulation research

These findings support FDA-cleared indications. They are not Medicare coverage criteria for E0745.

VEINOPLUS® electrodes on the calf, with arrows illustrating blood flow in the leg

FDA-cleared indications (K072252)

  • Relaxation of muscle spasms
  • Prevention or retardation of disuse atrophy
  • Increasing local blood circulation
  • Muscle re-education
  • Immediate post-surgical stimulation of calf muscles to prevent venous thrombosis
  • Maintaining or increasing range of motion

Not a substitute for guideline-directed VTE prophylaxis.

ELECTRO-PAD RCT

73 adults with lower-extremity PAD. Three months of home calf NMES vs. usual care: between-group difference in maximal treadmill walking distance +69.9 m (P=0.02). The manufacturer of VEINOPLUS® supplied the stimulators and provided financial support.

Le Faucheur A, et al. Eur J Prev Cardiol. 2026. doi:10.1093/eurjpc/zwag080

Arterial inflow

15 adults with stable claudication. Calf stimulation with VEINOPLUS® increased femoral arterial inflow in the stimulated limb vs. the non-stimulated limb.

Abraham P, et al. J Vasc Surg. 2013;57(3):714–719. doi:10.1016/j.jvs.2012.08.117

Venous flow

24 volunteers. Stimulated calf contractions increased popliteal venous velocity and total venous volume flow above resting baseline.

Griffin M, et al. Eur J Vasc Endovasc Surg. 2010;40(6):766–771. doi:10.1016/j.ejvs.2010.06.019

Listen: the calf muscle pump

From practices

In clinical practice

The device

Small enough for a pocket

What your patient uses

  • Pocket-sized
  • Two calf electrodes
  • 60-minute session with auto-off
  • One session, 1–3×/day per physician direction
  • Usable while walking
  • Reusable
Dr. Jozef Cywinski at his desk

The VEINOPLUS® stimulation pattern was designed by Dr. Jozef Cywinski, a specialist in electrical muscle stimulation.

Contraindications

  • Implanted electronic devices, e.g., pacemakers
  • Active DVT at the treatment site
  • Severe arterial insufficiency
  • Uncontrolled congestive heart failure

Consult the IFU for complete indications, contraindications, warnings, and precautions.

Veterans & Federal

VEINOPLUS® for veterans

VA internal PSAS/FSS procurement is not bound by NCD criteria, so the full FDA-cleared scope applies: relaxation of muscle spasms; prevention or retardation of disuse atrophy; increasing local blood circulation; muscle re-education; immediate post-surgical stimulation of calf muscles to prevent venous thrombosis; maintaining or increasing range of motion.

Not a substitute for guideline-directed VTE prophylaxis.

Service-Disabled Veteran-Owned Small Business badge GS2, Government Solutions and Services
  • FSS 36F79723D0020
  • DUNS 116835357
  • CAGE 88D93
  • SDVOSB

How VA orders it

  1. Community provider submits an RFS (VA Form 10-10172).
  2. Prosthetics/PSAS purchases off FSS 36F79723D0020 via GS2.

Community Care/CCN follows Medicare rules (NCD 160.12).

Contract holder

GS2 Global (Government Solutions and Services, LLC; SDVOSB)

SPD@GS2GLOBAL.COM
(502) 475-4199

Download VA Ordering Sheet

Request info

Tell us what your practice needs

C2 Medical responds within 24 hours.

Add details (optional)

No patient information here or by email. PHI goes only to HIPAA-secure fax (321) 641-4230.

Your information is shared only with C2 Medical. We do not sell or share provider data.

Inquiry Received!

C2 Medical will follow up within 24 hours. Check your email for a confirmation.

Contact

Reach C2 Medical

  • Talk to C2 Medical: (312) 804-1050Call or text
  • Email: hello@thecalfpump.comGeneral questions only. Do not send patient information.
  • HIPAA-secure fax: (321) 641-4230Orders and all PHI
  • 24/7 AI product assistant: (689) 263-7980Automated assistant, not a person
  • Mailing address: 7025 County Rd 46A, Ste 1071-152, Lake Mary, FL 32746Mail only. Send orders and patient information by fax.

Talk to our AI assistant

Talk to our AI

24/7 AI product assistant, not a person: (689) 263-7980. Calls are recorded.

C2 Medical LLC (Rep #1900) is an authorized independent distributor of VEINOPLUS® on behalf of DynaPulse Medical LLC.

Important Safety Information

Rx Only. Caution: Federal law restricts this device to sale by or on the order of a licensed healthcare practitioner.

Indications for Use (K072252): Relaxation of muscle spasms; prevention or retardation of disuse atrophy; increasing local blood circulation; muscle re-education; immediate post-surgical stimulation of calf muscles to prevent venous thrombosis; maintaining or increasing range of motion. Not a substitute for guideline-directed VTE prophylaxis.

Contraindications: Implanted electronic devices (e.g., pacemakers); active DVT at the treatment site; severe arterial insufficiency; uncontrolled congestive heart failure.

Consult the VEINOPLUS® IFU (instructions for use) for complete indications, contraindications, warnings, and precautions. Device selection should be made by a licensed healthcare provider. Individual results may vary.

Medicare may cover VEINOPLUS® (E0745) for disuse muscle atrophy when NCD 160.12 criteria are met and documented. Coverage is determined by each payer. General information only, not medical, billing, or legal advice, and not a guarantee of coverage or payment. VEINOPLUS® is a registered trademark of its respective owner.

Get the Rx Form Request a Demo Unit